The journal targets bioscience industry professionals, healthcare professionals and service providers to the life sciences sector.
The news, features and case studies in PiP cover three broad areas:
1. Joint working – pharma, biotech and medtech companies and relevant service providers working in partnership with healthcare providers and academics to meet the medical challenges of the 21st century.
2. Open innovation – collaboration between companies in different life science sectors (e.g. pharma and biotech) to discover, develop and commercialise innovative therapies such as personalised medicines.
3. Healthcare access – life science companies working with media or public sector organisations to provide health education and improve public health by increasing access to healthcare resources worldwide.
PiP is a forum for exploration, discussion and promotion of the role of business partnerships in the progress of biomedical science – bringing together key skills, knowledge and ideas to break new ground in healthcare.
Themes covered in the first issue include: joint working with the NHS; partnership and the PM Society; a beginner’s guide to open innovation; the intellectual property issues around open innovation; the Open Lab project to develop new therapies for global diseases; and the GAVI Alliance to make life-saving vaccines available in the developing world.
The first issue also features case studies of successful partnership working from four consultancies to the life sciences industry: ZS Associates, Ashfield in2Focus, WG Consulting and Soar Beyond.
It also introduces a new contact service, Healthcare Friends, to bring together life science companies, service providers, NHS organisations and other stakeholders seeking partners to take healthcare innovation forward.
For a free subscription, click on http://tinyurl.com/pje9eat